Abstract

The early detection and grading of gliomas is important for treatment decision and assessment of prognosis. Over the last decade numerous automated computer analysis tools have been proposed, which can potentially lead to more reliable and reproducible brain tumor diagnostic procedures. In this paper, we used the gradient-based features extracted from structural magnetic resonance imaging (sMRI) images to depict the subtle changes within brains of patients with gliomas. Based on the gradient features, we proposed a novel two-phase classification framework for detection and grading of gliomas. In the first phase, the probability of each local feature being related to different types (e.g., diseased or healthy for detection, benign or malignant for grading) was calculated. Then the high-level feature representing the whole MRI image was generated by concatenating the membership probability of each local feature. In the second phase, the supervised classification algorithm was used to train a classifier based on the high-level features and patient labels of the training subjects. We applied this framework on the brain imaging data collected from Zhongnan Hospital of Wuhan University for glioma detection, and the public TCIA datasets including glioblastomas (WHO IV) and low-grade gliomas (WHO II and III) data for glioma grading. The experimental results showed that the gradient-based classification framework could be a promising tool for automatic diagnosis of brain tumors.

Highlights

  • Gliomas are a group of primary brain tumors that arise from glial cells of the central nervous system (CNS)

  • Since we extracted Histogram of Oriented Gradients (HOG) features slice by slice and combined their clustered results into one feature vector representing the whole 3D magnetic resonance imaging (MRI) image, our random data shuffling for CV is subject-separated

  • We evaluated the performance of our proposed two-phase classification model using the following measurements: accuracy (ACC), sensitivity (SEN), specificity (SPE), and area under curve (AUC)

Read more

Summary

Introduction

Gliomas are a group of primary brain tumors that arise from glial cells of the central nervous system (CNS). Glioma Diagnosis With AI histopathological and genotypic features in the classification of these tumors (Louis et al, 2016) In this classification, WHO grade II and III are grouped under the low-grade glioma (LGG) category since they share common IDH mutations. The determination of glioma grade depends on several histopathological features including mitotic activity, cytological atypia, neoangiogenesis, and tumor necrosis (Hsieh et al, 2017b). These features are not always easy to be recognized, and physicians may have different views about them, some misdiagnosis can still happen due to glioma heterogeneity or subjective judgments by physicians. The surgery needs to resect some normal brain tissues, which may lead to sequelae, dysfunction or even functional loss after surgery

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call